Navigation Links
Study confirms everolimus can overcome trastuzumab resistance in HER-2 positive early breast cancer
Date:5/2/2013

Lugano-CH, Brussels-BE, 2 May 2013 -- A study that aimed to understand how the cancer drug everolimus helps overcome the resistance breast cancers can develop to trastuzumab has left researchers contemplating a puzzle.

The study showed a statistically non-significant benefit in clinical response rates for some patients with early breast cancer when everolimus was added to treatment with trastuzumab. Yet the results suggest this benefit is achieved independently of the molecular pathways researchers expected would be involved.

Prof Mario Campone, Principal Investigator at Institut Cancerologie de l'Ouest in Nantes, France, presented the findings at the 5th IMPAKT Breast Cancer Conference in Brussels, Belgium. The IMPAKT meeting presents cutting edge, 'translational' breast cancer research that is beginning to have an impact for patients.

"As more targeted cancer drugs are developed, the challenge is to identify which patients will benefit from individual agents," Prof Campone said. "One of the objectives of this study was to determine molecular biomarkers that predict whether a patient's cancer is sensitive to the combination of everolimus and trastuzumab compared to trastuzumab alone."

Trastuzumab is a monoclonal antibody targeted against the HER2 tyrosine kinase receptor. Many patients who initially respond to trastuzumab develop resistance.

In preclinical studies, everolimus, an oral inhibitor of an important molecule called mammalian target of rapamycin (mTOR), has demonstrated an ability to reverse trastuzumab resistance. However, the mechanisms of action involved in the reversion of trastuzumab resistance are not completely understood.

"Resistance to trastuzumab may result from several molecular alterations occurring at different levels of the downstream effectors in the PI3K/AKT pathway, all of them resulting in maintenance of signal transduction," Prof Campone explains. "Therefore, using everolimus to inhibit mTOR, a major downs
'/>"/>

Contact: Vanessa Pavinato
media@esmo.org
European Society for Medical Oncology
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Study reveals magnitude of variation in gene expression measurements within breast cancers
2. Study opens new prospects for developing new targeted therapies for breast cancer
3. Breast cancer heterogeneity no barrier to predictive testing, study shows
4. BUSM study shows positive impact of mind-body course on well-being of medical students
5. Study finds possible alternative to bariatric weight loss surgery
6. Zebrafish study suggests that vitamin B2 (riboflavin) is an antidote to cyanide poisoning
7. Study examines effects of genetic variants for infants with neonatal abstinence syndrome
8. University of Houston engineering professor awarded grant to study melanoma treatment
9. Monoclonal Antibody with Xencors High ADCC Fc Technology Enters Phase 2 Study in B-cell Acute Lymphoblastic Leukemia
10. BUSM study reveals novel mechanism by which UVA contributes to photoaging of skin
11. Study led by NUS scientists reveals escalating cost of forest conservation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2015)... , June 23, 2015  Crossmatch™, ... and authentication solutions, today announced enhanced functionality of ... authentication solution.  The enhancements build on the ... the DigitalPersona Altus platform and provide expanded ... In today,s environment of increasing ...
(Date:6/17/2015)... Germany , June 17, 2015 ... Standard: QIA) today launched new Investigator ® STR assay ... the United States . The new genetic ... key genomic markers (short tandem repeats or STRs) for DNA ... evaluate the quality of DNA in each sample, a novel ...
(Date:6/16/2015)... 16, 2015  With the increasing number and severity ... top concern. The recent compromise of Federal employee ... strong authentication within government agencies. HYPR Corp. ... password (OTP) authenticator, has been submitted for testing and ... 3 validation for tamper proofing. The ...
Breaking Biology News(10 mins):Crossmatch Releases Enhanced DigitalPersona Altus Advanced Authentication Functionality 2QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 2QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 3QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 4QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 5Government Ready Biometric Security Approaching as HYPR Corp. Files FIPS 140-2 Level 3 Validation for Its Proprietary Biometric Token 2Government Ready Biometric Security Approaching as HYPR Corp. Files FIPS 140-2 Level 3 Validation for Its Proprietary Biometric Token 3
... 24, 2010 The National Science Foundation this week ... American Society for Biochemistry and Molecular Biology to establish ... nation. The initiative aims to improve undergraduate-level teaching ... and skills for the discipline and by developing appropriate ...
... MADISON, WI, June, 2010 The approach the ... gas emissions from agricultural anaerobic lagoons that treat manure ... to 65%, according to scientists from the University of ... feeding operations prior to application to crops as a ...
... the earth,s atmospheric composition are likely to alter plant ... reach levels double those of the preindustrial era by ... food for a rapidly growing population. University ... carbon dioxide, elevated ozone and higher atmospheric temperatures on ...
Cached Biology News:NSF grant will develop new online hub for biochemistry, molecular biology educators 2Scientists question EPA estimates of greenhouse gas emissions 2Climate change complicates plant diseases of the future 2Climate change complicates plant diseases of the future 3
(Date:6/30/2015)... ... June 30, 2015 , ... Matrix Marketing Group, ... it has hired Gem Swartz to head up its account management department as vice ... Both Gem and Amanda bring senior account management and delivery expertise to the growing ...
(Date:6/30/2015)... ... 30, 2015 , ... Southern Illinois University Edwardsville Chancellor Julie ... president of instruction at Chippewa Valley Technical College (CVTC) and will assume her ... lead SIUE during the past three years,” Furst-Bowe said. “I want to thank ...
(Date:6/29/2015)... KS (PRWEB) , ... June 29, 2015 , ... ... PATENT 7736892 B2. Under the terms of the agreement, MediVet will acquire the ... Stem Cells (UCMSCs). MB-007 is currently in pre-clinical development as a potential next-generation ...
(Date:6/29/2015)... 29, 2015  Neuralstem, Inc. (NYSE MKT: CUR), a ... small molecule and cell therapy treatments for central nervous ... for listing on the NASDAQ Capital Market under the ... trade on the NYSE MKT until the market close ... Market is expected to commence on July 13, 2015. ...
Breaking Biology Technology:Matrix Marketing Group Expands Client Services Team 2SIUE’s Furst-Bowe Accepts VP of Instruction at CVTC 2SIUE’s Furst-Bowe Accepts VP of Instruction at CVTC 3MediVet Biologics Acquires Exclusive Patent License from Kansas State University 2MediVet Biologics Acquires Exclusive Patent License from Kansas State University 3Neuralstem, Inc. Announces Approval for Listing on the NASDAQ Capital Market 2Neuralstem, Inc. Announces Approval for Listing on the NASDAQ Capital Market 3
... by the British Heart Foundation (BHF), has tested a new ... patient,s risk of having a heart attack (1). ... Research Excellence, in collaboration with the University of Cambridge are ... CT scanning to image the disease processes directly in the ...
... age of high-speed computing, the photon is king. However, producing ... time-consuming process, until now. Thanks to the work by ... The Edward S. Rogers Sr. Department of Electrical & Computer ... the production of special class of photons faster and easier. ...
... ALBANY, N.Y., April 30, 2012   AMRI ... an approach that further focuses its research and ... the life sciences and other industries. AMRI SMARTSOURCING™ ... customers to reach more successful outcomes. SMARTSOURCING™ is ...
Cached Biology Technology: Scientists develop new technique that could improve heart attack prediction 2Research breakthrough takes supercomputing out of the lab 2AMRI Launches SMARTSOURCING™ For Contract Manufacturing and Research Services 2
BBS/Glycerol/Casein Block and Diluent - 10X Concentrate, 1 L...
Ms anti-Cyclophilin D...
From micro to giga sizes, from single prep to high-throughput, Invitrogen's range of plasmid purification kits offers superior performance to match the demands of your downstream application....
... Upright Freezer Inventory Storage Racks ... configurations available to fit all makes ... refrigerators. Made of high quality ... 3" high fiberboard, stainless steel or ...
Biology Products: